Therapeutic Solutions International Inc (TSOI)

[centsability4me]

kirk5 ,

I was thinking the same thing about the company working on all these patents , but not getting the funding yet to continue these startups .So - we know we that the first patents involved with these startups are just now starting to clear the process . Now comes the clinical trials associated with some of them , and the manufacturing process beginning with others . This is one of those times that our PPS is in ?, so those of you that want to pick up some cheap shares , this might be one of those opportune times . The company did make good on their promises to catch up on 3 years of filings , and they also cancelled a reverse split, so I am hanging tight and waiting for what the near future brings us. Don't forget that at this point in time , there are are big holders that haven't sold any big blocks that i know of , so they are patiently waiting also .-IMHO -Cents

From the last Q filing :

https://www.sec.gov/Archives/edgar/data/1419051/000107878217001602/f10q093017_10q.htm

OmniBiome, Inc., (“OMNI”) - is a majority-owned subsidiary of TSOI, incorporated in the State of Delaware on October 20, 2015, where the intellectual property surrounding probiotics is housed. OMNI is focused on therapeutic / RX approaches to either utilize or intervene with systemic effects of the vaginal, lactal-duct and oral microbiomes for improving maternal heathcare and resulting birth outcomes. The Officers and Directors of the Company are also Officers and Directors of OMNI. As of September 30, 2017 and November 15, 2017, TSOI owns approximately 73.75% of the outstanding share of OMNI. As of September 30, 2017 and November 15, 2017, formal operations have not commenced.



Emvolio, Inc., (“EMVO”) – is a wholly-owned subsidiary of TSOI, incorporated in the State of Delaware on October 3, 2016, where the intellectual property surrounding immune-oncology is housed. EMVO intends to develop products that can be used together to attack cancer at different levels, as well as to be used alone or in combination with existing therapies. The Officers and Directors of the Company are also the Officers and Directors of EMVO. As of September 30, 2017 and November 15, 2017, formal operations have not commenced.

SandBox Dental Labs, Inc., is a wholly-owned subsidiary of TSOI consisting of a dental laboratory to manufacture and fill prescriptions from dentists who will use our exclusively licensed Sleep Appliance to treat their patients with mild to moderate obstructive sleep apnea. The Officers and Directors of the Company are also the Officers and Directors of SandBox. As of September 26, 2017, limited operations have begun.